×

Global Intravenous Immunoglobulin (IVIg) Market Research Report 2017

Published Date: 17-11-08   |   Pages: 110   |   Tables: 133   | Report Id: 110929   | Hits: 9 |   IVIg



In this report, the global Intravenous Immunoglobulin (IVIg) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.


Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Intravenous Immunoglobulin (IVIg) in these regions, from 2012 to 2022 (forecast), covering

North America

Europe

China

Japan

Southeast Asia

India

Global Intravenous Immunoglobulin (IVIg) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

CSL Behring

Grifols

Octapharma

Shire

ADMA Biologics

Bayer

Bharat Serum and Vaccines

Biotest

China Biologic Products

Hualan Biological Engineering

Kedrion Biopharma

Sanquin

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Neurology

Hematology

Immunology

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Immunology

Oncology

Pulmonology

Rheumatology

Transplant

Neurology

Hematology

Others


If you have any special requirements, please let us know and we will offer you the report as you want.


Licenses Type

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehnsive analysis
 Excellent after sales support
 Owns large database

Need Help ?

QYR Clients

More Clients...